CBPO Insider Trading Activity and SEC Form 4 Filings
CBPO insider trading summary
No open-market insider purchases or sales of China Biologic Products, Inc. (CBPO) have been reported on SEC Form 4 in the past 12 months.
Latest CBPO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 9, 2017 | Zhijing CBPO Liu | Corporate Vice President | Sell | $132K (1,142 @ $115.40) |
| May 8, 2017 | Zhijing CBPO Liu | Corporate Vice President | Sell | $742K (6,358 @ $116.68) |
| Mar 2, 2017 | Sean Shao | Director | Sell | $1.6M (16,000 @ $100.80) |
| Mar 1, 2017 | David Gao | Chief Executive Officer | Sell | $5.4M (54,049 @ $100.57) |
| Mar 1, 2017 | Sean Shao | Director | Sell | $403K (4,000 @ $100.70) |
| Feb 28, 2017 | David Gao | Chief Executive Officer | Sell | $6.3M (62,604 @ $100.69) |
| Aug 15, 2016 | Ming Yang | Chief Financial Officer | Sell | $2.6M (21,092 @ $124.32) |
| Aug 15, 2016 | Zhijing CBPO Liu | Corporate Vice President | Sell | $245K (1,968 @ $124.32) |
| Aug 15, 2016 | Ming Yin | Sr. Corporate Vice President | Sell | $2.5M (20,334 @ $124.32) |
| Aug 15, 2016 | Wenfang Liu | Director | Sell | $361K (2,900 @ $124.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.